6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Sleep Disturbances in Substance Users
Sleep disturbances are a common and debilitating issue among individuals with substance use disorders. Substances like alcohol, stimulants, and opioids disrupt natural sleep patterns, leading to insomnia, fragmented sleep, or hypersomnia. Prolonged substance use alters the brain's circadian rhythms and sleep architecture, often exacerbating mental health challenges such as anxiety and depression. Addressing sleep disturbances is a critical component of recovery, as poor sleep can increase the risk of relapse. Behavioral interventions like sleep hygiene education and cognitive-behavioral therapy for insomnia (CBT-I) are effective in restoring healthy sleep. Medications, such as melatonin agonists or sedating antidepressants, may also be considered. Treating sleep issues alongside addiction fosters better overall recovery outcomes.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States